Epidermolysis Bullosa Acquisita
Fig. 61.1 Severe scarring lesions in EBA. (a) Flexion contractures of the fingers, (b) loss of nails, (c) erosions, synechia, and webbing of esophagus observed by endoscopy, (d) end-stage ocular…
Treatment of Dermatitis Herpetiformis
© Springer-Verlag Berlin Heidelberg 2015Dédée F. Murrell (ed.)Blistering Diseases10.1007/978-3-662-45698-9_60 60. Treatment of Dermatitis Herpetiformis Robert George1, Adela Rambi G. Cardones2, Dédée F. Murrell3 and Russell P. HallIII2 (1) Department of Dermatology, St. George Hospital, Sydney, NSW, Australia (2) Department of Dermatology, Duke…
Mucous Membrane Pemphigoid
© Springer-Verlag Berlin Heidelberg 2015Dédée F. Murrell (ed.)Blistering Diseases10.1007/978-3-662-45698-9_59 59. Mucous Membrane Pemphigoid Frédéric Caux1 and Catherine Prost-Squarcioni1, 2 (1) Department of Dermatology, Reference Center for Autoimmune Bullous Diseases, Avicenne Hospital, Bobigny, France (2) Department of…
Management of Linear IgA Disease in Adults
© Springer-Verlag Berlin Heidelberg 2015Dédée F. Murrell (ed.)Blistering Diseases10.1007/978-3-662-45698-9_58 58. Management of Linear IgA Disease in Adults Caroline P. Allen1 and Vanessa A. Venning1 (1) Department of Dermatology, The Churchill Hospital, Oxford, UK Caroline P. Allen Email: caroline.allen@gmail.com…
Treatment of Chronic Bullous Disease of Childhood
(1) Department of Dermatology, Columbia University, New York, NY, USA (2) Department of Dermatology, Morgan Stanley Children’s Hospital of New York-Presbyterian, Columbia University, New York, NY, USA 57.1 Introduction…
Current Management of Pemphigoid Gestationis
Pregnancy categorya First line: Topical corticosteroids C Systemic corticosteroids C Others: Tetracyclines D Nicotinamide D Cyclophosphamide D Cyclosporin C Azathioprine D Dapsone C IVIg C Rituximab C Plasmapheresis Unclassified…
Management of Bullous Pemphigoid
© Springer-Verlag Berlin Heidelberg 2015Dédée F. Murrell (ed.)Blistering Diseases10.1007/978-3-662-45698-9_55 55. Management of Bullous Pemphigoid Mae N. Ramirez-Quizon1 , Luca Borradori2 , Russell P. HallIII3 and Dédée F. Murrell4 (1) Department of Dermatology, St George Hospital, Sydney, NSW, Australia (2) Department of Dermatology, University…
The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus
© Springer-Verlag Berlin Heidelberg 2015Dédée F. Murrell (ed.)Blistering Diseases10.1007/978-3-662-45698-9_54 54. The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus Jaehwan Kim1 , Benjamin S. Daniel2 , Victoria P. Werth3 , Pascal Joly4 and Dédée F. Murrell5 (1) Laboratory for Investigative Dermatology, The Rockefeller University, New York,…
Rituximab and Its Use in Autoimmune Bullous Disorders
4. Sanz I. Indications of rituximab in autoimmune diseases. Drug Discov Today Ther Strateg. 2009;6(1):13–9.CrossRefPubMedCentralPubMed 5. Nagel A, Hertl M, Eming R. B-cell-directed therapy for inflammatory skin diseases. J Investig…
Cyclophosphamide in Autoimmune Blistering Diseases: Safety, Efficacy and Evidence Base
Fig. 51.1 Pharmacology of cyclophosphamide. Cyclophosphamide is metabolised by the hepatic cytochrome P450 enzymes including CYP3A4 and CYP2B6 to form the active metabolite 4-hydroxy-cyclophosphamide. As the active hydroxylated cyclophosphamide is…
